Pill Identifier App

Molecular Insight Pharmaceuticals, Inc. To Present Results from a Prospective Analysis of Zemiva Phase 2b Data at the 2008 Scientific Sessions of the American Heart Association

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 9, 2008 - Poster Session #: APS.43.1

Poster Session Title: ACS: Initial Assessment - Old and New Tools

Poster Board #: C5

Date: Sunday, November 9, 2008

Time: 9:30 am - 11:00 am Central Time

Location: Ernst N. Morial Convention Center, Hall A-B1

Authors: Michael C. Kontos, Virginia Commonwealth University, Richmond, VA; Jonathan L. Goldman, ICON Medical Imaging, Warrington, PA; John W. Babich, Yong Li, Katherine Kacena and Norman LaFrance, Molecular Insight Pharmaceuticals, Inc., Cambridge, MA; James E. Udelson, Tufts Medical Center, Boston, MA

Contact

Molecular Insight Pharmaceuticals, Inc.
Deborah S. Lorenz, 617-871-6667
Senior Director
Investor Relations and Corporate Communications
dlorenz@molecularinsight.com

Posted: November 2008

View comments

Hide
(web4)